Dilution Risk Tracker

Why dilution matters

When a company issues new shares, every existing shareholder is left owning a smaller slice of the same business. That is dilution, and for small- and mid-cap stocks it is one of the most common — and most overlooked — reasons a price grinds lower even when the headlines look fine.

The catch is that dilution is disclosed in plain sight, scattered across dozens of dense SEC filings: shelf registrations, prospectus supplements, 8-Ks announcing offerings, convertible-note terms, warrant agreements. By the time a trader pieces it together, the damage is often done. Wiseek's Dilution Risk Tracker reads those filings for you and distills them into a single, comparable signal.

What we detect

Dilution is not one event — it is a family of them, each with a different mechanism and a different level of harm. Wiseek's models are tuned to recognize the full range as it appears in filings:

• At-the-market (ATM) programs — the quiet, continuous sale of new shares into the open market, often the single most persistent source of dilution.
• Shelf registrations (S-1, S-3, S-3ASR) — capacity to issue shares later; an overhang that signals intent, not yet action.
• Follow-on, registered-direct and secondary offerings — priced capital raises, including deeply discounted deals that pressure the stock.
• Convertible notes and preferred stock — debt that converts into shares, especially variable-priced or "toxic" structures that convert at a discount.
• Warrants and inducement deals — including repricings and exercise inducements that pull forward and enlarge share issuance.
• Equity lines and standby purchase agreements (ELOCs) — committed facilities to sell stock on demand.
• Reverse splits — frequently a precursor to, or companion of, heavy dilution and distress.

How it works

Wiseek's models read the SEC filings of roughly 6,800 U.S.-listed companies in real time. For dilution specifically, the pipeline runs in four layers:

• 1. Identify. Every filing is classified by form type and screened for dilution-specific language and structures — not keyword matching, but our own models trained on the way capital raises are actually written, including the difference between a dilutive raise and an explicitly non-dilutive one.
• 2. Grade. Each signal is assigned a severity, distinguishing a routine shelf from a deeply discounted offering or a variable-priced convertible.
• 3. Group. A single capital raise often generates five or more filings — the shelf, the prospectus supplement, the pricing 8-K, the closing 8-K. We collapse those into one campaign, so frequency reflects real events, not paperwork.
• 4. Score. Each ticker is rolled up into one of four levels, weighing active raises, ATM activity, shelf overhang, reverse splits and severity.

The result refreshes continuously as new filings arrive, and it powers both the Dilution Risk scanner and the dilution panel on every covered ticker page.

What the levels mean

• None   No dilution-related filing in the recent coverage window.
• Low   A minor or capacity-only signal, such as a single shelf registration.
• Moderate   Active dilution — a live ATM program or repeated offerings.
• High   Aggressive or distress-linked dilution — discounted offerings, toxic or variable-priced convertibles, warrant inducements, or reverse-split-driven issuance.

Coverage and limitations

We believe in being precise about what this signal is. It is filing-implied: it reflects what a company has disclosed, scored by type, frequency and severity. It is not a realized share count, and it does not yet normalize the dollar size of a raise against a company's market value — so a multi-billion-dollar raise at a mega-cap and a small repeat offering at a micro-cap can read differently than their absolute size suggests. Always open the underlying filing for exact figures.

Coverage spans U.S.-listed companies that file with the SEC; foreign private issuers reporting only on Form 6-K, and events outside our recent window, may be incomplete. The Dilution Risk Tracker is a research screen to help you find what to investigate — it is not investment advice.